{"product_id":"schrodinger-business-model-canvas","title":"Schrödinger Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSchrödinger's Business Blueprint Unveiled!\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eCurious about Schrödinger's innovative approach to business? Our full Business Model Canvas unpacks exactly how they create and deliver value, from their unique customer relationships to their revenue streams. Discover the strategic framework that fuels their success.\u003c\/p\u003e\n\u003cp\u003eWant to dissect Schrödinger's winning strategy? The complete Business Model Canvas provides a comprehensive, section-by-section breakdown of their operations, partnerships, and cost structure. Download it now to gain a competitive edge.\u003c\/p\u003e\n\u003cp\u003eUnlock the secrets behind Schrödinger's market impact with our detailed Business Model Canvas. This professionally crafted document reveals their core activities, key resources, and value propositions, offering invaluable insights for your own ventures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSchrödinger’s key partnerships with major pharmaceutical companies are crucial for advancing its drug discovery platform. These collaborations are designed to speed up the identification and development of new therapies, sharing both the risks and potential rewards involved.  For instance, Schrödinger has ongoing, expanded collaborations with industry giants like Eli Lilly and Company and Ots Otsuka Pharmaceutical Co., Ltd.\u003c\/p\u003e\n\u003cp\u003eA significant example of these strategic alliances is the multi-target research collaboration with Novartis. This partnership, announced in 2023, included an initial upfront payment of $150 million. Furthermore, it holds the potential for milestone payments totaling up to $2.3 billion, contingent on the successful progression of drug candidates through development and regulatory approval.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiotechnology Firms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSchrödinger actively collaborates with numerous biotechnology firms, utilizing its advanced computational platform to jointly develop promising drug candidates. This strategic approach broadens Schrödinger's therapeutic area expertise and fosters shared innovation in the crucial field of molecular discovery.\u003c\/p\u003e\n\u003cp\u003eA prime illustration of this partnership model is the deepened research collaboration initiated with Ajax Therapeutics in 2024, aiming to accelerate the discovery of novel therapies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSchrödinger actively partners with top universities and government research labs, like those involved in the National Cancer Institute's Structural Biology program, to push the boundaries of computational chemistry. These collaborations are crucial for developing new scientific insights and cultivating the next generation of computational scientists.\u003c\/p\u003e\n\u003cp\u003eThrough these academic alliances, Schrödinger grants access to its cutting-edge software, funds vital research projects, and offers educational licenses. In 2024, such initiatives directly contributed to advancements in drug discovery pipelines, as evidenced by multiple publications in high-impact journals stemming from these joint efforts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and AI Research Collaborators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSchrödinger's collaborations with technology and AI research entities are fundamental to its mission. These partnerships are key to advancing its computational chemistry and drug discovery platforms, particularly by integrating cutting-edge AI and machine learning techniques. For example, their work with NVIDIA focuses on leveraging advanced AI for predictive toxicology, a critical area for drug development efficiency.\u003c\/p\u003e\n\u003cp\u003eThese alliances are designed to bolster Schrödinger's core technological infrastructure. By partnering with leading cloud providers and hardware specialists, the company ensures its platform benefits from the latest in GPU computational acceleration and robust cloud computing infrastructure. This technological backbone is essential for handling the immense data processing demands of sophisticated molecular simulations.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eAI \u0026amp; Machine Learning Integration:\u003c\/strong\u003e Partnerships enable the continuous refinement of predictive models, directly impacting the accuracy and speed of drug candidate identification.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComputational Power Enhancement:\u003c\/strong\u003e Collaborations with technology firms provide access to and integration of advanced GPU technologies and scalable cloud computing resources.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePredictive Toxicology Initiatives:\u003c\/strong\u003e Joint efforts, such as those with NVIDIA, apply AI to physics-based platforms to improve the prediction of potential drug toxicities early in the development cycle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePlatform Scalability \u0026amp; Efficiency:\u003c\/strong\u003e These partnerships are vital for ensuring Schrödinger's platform can scale effectively to meet the growing complexity and volume of research demands.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCo-founded Companies and Spin-offs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSchrödinger's strategy includes co-founding companies and spinning off ventures, such as Structure Therapeutics and Ajax Therapeutics. This approach validates its core platform and creates multiple avenues for financial returns.  These partnerships allow Schrödinger to leverage its technology in specific therapeutic areas, generating revenue through equity, milestone payments, and royalties as drug candidates progress.\u003c\/p\u003e\n\u003cp\u003eThis co-founding model enables Schrödinger to directly benefit from the commercialization of drugs discovered using its computational platform. For instance, Structure Therapeutics, a company co-founded by Schrödinger, focuses on developing novel therapeutics for fibrotic and metabolic diseases.  As of early 2024, Structure Therapeutics has advanced several programs into clinical trials, demonstrating the tangible output of this partnership strategy.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003eCo-founding ventures like Structure Therapeutics and Ajax Therapeutics validates Schrödinger's platform.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFinancial gains are realized through equity stakes, milestone payments, and royalties from these spin-offs.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eThis model allows direct participation in the development and commercialization of drug candidates.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eStructure Therapeutics, a Schrödinger co-founded company, has advanced multiple programs into clinical development by early 2024.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Partnerships: Driving Drug Discovery and Biotech Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSchrödinger's key partnerships are vital for its drug discovery engine, fostering collaborations with major pharmaceutical and biotechnology companies. These alliances, including expanded work with Eli Lilly and Otsuka Pharmaceutical, aim to accelerate therapeutic development.  The company also strategically partners with academic institutions and research labs to advance computational chemistry, as seen in its work with the National Cancer Institute's Structural Biology program.\u003c\/p\u003e\n\u003cp\u003eSchrödinger’s collaborations with technology and AI firms, such as NVIDIA, are crucial for enhancing its computational chemistry and drug discovery platforms. These partnerships focus on integrating advanced AI and machine learning for improved predictive toxicology and overall platform efficiency.  By working with leading cloud providers, Schrödinger ensures access to powerful computational resources, essential for complex molecular simulations.\u003c\/p\u003e\n\u003cp\u003eThe company also actively co-founds and spins off ventures, like Structure Therapeutics and Ajax Therapeutics, to leverage its technology and generate returns. This model allows Schrödinger to directly benefit from the commercialization of drugs developed using its platform, with companies like Structure Therapeutics advancing programs into clinical trials by early 2024.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA structured framework for visualizing and analyzing a business's core components, fostering strategic alignment and operational clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThe Schrödinger Business Model Canvas helps alleviate the pain of uncertainty by visualizing potential business outcomes and their associated risks, allowing for informed decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware Development and Enhancement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSchrödinger's core activity revolves around the relentless research and development of its sophisticated physics-based computational platform. This commitment to innovation means constantly refining existing software, building out new functionalities, and incorporating cutting-edge AI and machine learning to maintain leadership in computational chemistry and materials science.\u003c\/p\u003e\n\u003cp\u003eA substantial portion of Schrödinger's resources is dedicated to this continuous improvement. In 2024, the company invested approximately $100 million in research and development, underscoring its strategic focus on enhancing its software solutions and staying ahead of technological advancements in its field.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Drug Discovery and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSchrödinger actively pursues its own drug discovery and development initiatives. The company utilizes its advanced computational platform to pinpoint and advance promising new drug candidates, aiming to build a robust internal pipeline.\u003c\/p\u003e\n\u003cp\u003eThe company anticipates receiving initial clinical data from three of its key proprietary programs during 2025. This milestone is crucial for validating the efficacy and potential of their internally developed therapies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative Research and Project Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSchrödinger's key activities include managing extensive collaborations with pharmaceutical and biotech firms. This involves overseeing joint research and driving forward partnered drug discovery programs.  A significant aspect is advancing therapeutics for undisclosed targets within their partners' key therapeutic areas.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Schrödinger continued to emphasize these collaborative efforts. Their platform facilitates the identification and progression of novel drug candidates, a process that relies heavily on effective project management and shared scientific expertise.  The company's success is intrinsically linked to the seamless execution of these complex, multi-party research initiatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCustomer Support and Training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSchrödinger's commitment to customer support and training is paramount for the successful implementation of its sophisticated scientific software. They offer extensive resources, including dedicated technical support and comprehensive training programs, to ensure clients can fully leverage the platform's capabilities. This focus facilitates smooth integration and optimization, crucial for maximizing research efficiency.\u003c\/p\u003e\n\u003cp\u003eThe company provides advanced support tailored to complex integration needs, enabling customers to seamlessly incorporate Schrödinger's solutions into their existing research infrastructure. This hands-on assistance is vital for optimizing platform performance across diverse research environments, ensuring clients achieve their scientific objectives.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eDedicated Technical Support:\u003c\/strong\u003e Schrödinger offers specialized support to address intricate technical challenges encountered during software deployment and usage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Training Programs:\u003c\/strong\u003e Customers benefit from structured training modules designed to enhance their proficiency with Schrödinger's advanced computational platforms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntegration and Optimization Assistance:\u003c\/strong\u003e The company provides expert guidance for integrating its software into customer research sites, ensuring full operational efficiency.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCustomer Success Initiatives:\u003c\/strong\u003e Schrödinger actively engages in customer success programs to foster long-term adoption and maximize the value derived from its solutions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScientific Research and Publication\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSchrödinger's core activities heavily involve scientific research and publication. This is how they push the boundaries of computational chemistry and drug discovery, showcasing the power of their platform. By publishing in peer-reviewed journals, they build trust and demonstrate the real-world applicability of their work.\u003c\/p\u003e\n\u003cp\u003eA significant part of this research focuses on expanding their computational platform to predict toxicology risks. This vital area of research is supported by substantial funding, such as grants from prominent organizations like the Bill \u0026amp; Melinda Gates Foundation. These grants underscore the importance and potential impact of Schrödinger's scientific endeavors.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvancing Computational Chemistry:\u003c\/strong\u003e Schrödinger actively conducts fundamental scientific research to enhance its predictive capabilities in drug discovery and material science.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDemonstrating Platform Efficacy:\u003c\/strong\u003e Publishing peer-reviewed articles is a key strategy to validate and showcase the effectiveness of their computational platform to the scientific and pharmaceutical communities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSecuring Research Funding:\u003c\/strong\u003e Initiatives like developing predictive toxicology tools are supported by grants, with the Bill \u0026amp; Melinda Gates Foundation being a notable funder, enabling further scientific advancement.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaintaining Scientific Credibility:\u003c\/strong\u003e Consistent publication in reputable scientific journals is crucial for Schrödinger to establish and maintain its reputation as a leader in computational science.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComputational Platform Powers Drug Discovery \u0026amp; Materials Science\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSchrödinger's key activities are deeply rooted in the continuous advancement of its sophisticated physics-based computational platform, driving innovation in drug discovery and materials science. This involves significant investment in research and development, as demonstrated by their approximately $100 million R\u0026amp;D expenditure in 2024. Furthermore, the company actively pursues its own drug discovery programs, aiming to build an internal pipeline of promising new therapies, with initial clinical data anticipated from three key programs in 2025. Collaborations with leading pharmaceutical and biotech firms are also central, focusing on advancing partnered drug discovery initiatives and managing complex research projects.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eActivity\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003e2024 Data\/Milestone\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlatform R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eEnhancing physics-based computational software, incorporating AI\/ML.\u003c\/td\u003e\n\u003ctd\u003eInvested ~$100 million in R\u0026amp;D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProprietary Drug Discovery\u003c\/td\u003e\n\u003ctd\u003eIdentifying and advancing new drug candidates internally.\u003c\/td\u003e\n\u003ctd\u003eAnticipates initial clinical data from 3 programs in 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCollaborations\u003c\/td\u003e\n\u003ctd\u003eManaging joint research with pharma\/biotech partners.\u003c\/td\u003e\n\u003ctd\u003eFocus on advancing therapeutics for undisclosed targets.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Schrödinger Business Model Canvas preview you are viewing is an exact representation of the document you will receive upon purchase. This means the structure, content, and formatting are identical to the final deliverable, ensuring no surprises and immediate usability. You'll gain full access to this comprehensive tool, ready for immediate application to your business strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55611247296889,"sku":"schrodinger-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/schrodinger-business-model-canvas.png?v=1754753714","url":"https:\/\/growthsharematrix.com\/products\/schrodinger-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}